Nidazea (Metronidazole)

Metronidazole penetrates microbial cells in the skin and is reduced to reactive nitro radicals. These radicals damage microbial DNA and inhibit nucleic acid synthesis, leading to cell death. The drug also modulates inflammatory pathways, decreasing cytokine release and reducing skin redness.

The specific dosing regimen for Nidazea is determined by the prescribing healthcare professional based on the indication, severity of the condition, and patient factors. Patients should follow the prescriber's instructions and the product label for application frequency and duration.

Metronidazole is classified as pregnancy category B3, indicating that it should be used only if the potential benefit justifies any potential risk to the fetus. Limited systemic absorption from topical use makes it relatively safe, but pregnant or breastfeeding women should consult their healthcare provider before use.

To order Nidazea, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with other topical antibiotics such as clindamycin or erythromycin, metronidazole offers both antimicrobial and anti‑inflammatory actions, making it especially effective for rosacea. It has a lower risk of developing bacterial resistance and is generally well tolerated on the skin.

Nidazea should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture, direct sunlight, and excessive heat to maintain product stability.

Nidazea is applied topically to the affected skin area, typically once or twice daily as directed by a healthcare professional. The skin should be clean and dry before application, and the product should be spread in a thin layer and gently massaged until fully absorbed.

Serious risks, though rare, include severe allergic reactions such as angioedema, Stevens‑Johnson syndrome, and systemic neurotoxicity like peripheral neuropathy. Patients should seek immediate medical attention if they experience swelling of the face or throat, widespread skin blistering, or neurological symptoms.

Individuals with known hypersensitivity to metronidazole or any component of the formulation should avoid using Nidazea. It is also contraindicated on severely damaged or ulcerated skin, and caution is advised for pregnant women, breastfeeding mothers, and patients on interacting medications such as warfarin or alcohol.